Superior response with combination of interleukin-2 (IL-2) and granulocyte macrophage colony stimulating factor (GM-CSF) gene-modified tumor vaccines in myeloma
Wang J, Lu D, Butch AW, Rosen N, Saylors iii RL, Munshi NC. Superior response with combination of interleukin-2 (IL-2) and granulocyte macrophage colony stimulating factor (GM-CSF) gene-modified tumor vaccines in myeloma. 1998; 92:4228.